VentriPoint Diagnostics Ltd.

TSXV:VPT.V

$0.11 CAD

-$0.01 (-8.33%)

Volume
367.15K
Average Volume
154.11K
Market Capitalization
$17.11M
P/E Ratio
-3.44
Dividend Yield
0.00%
Price Target
$
Year High
$0.36
Year Low
$0.11
Payout Ratio
$0.00
Current Ratio
$0.28

Industry, Sector & symbol

Stock Exchange Toronto Stock Exchange Ventures
CEO Mr. Hugh MacNaught
Industry Medical - Devices
Sector Healthcare
Current Symbol VPT.V
CUSIP None
CIK None
Web https://www.ventripoint.com
Phone 416-848-4156
Currency CAD
Employees None
Country CA

Liquidity

Debt-to-Equity Ratio -0.47
Payout Ratio 0.00
Current Ratio 0.28
Quick Ratio 0.28
Cash Ratio 0.19

Sales & Book Value

Annual Sales $49183
Price / Sales 237.41
Cash Flow -0.03
Price / Cash Flow -4.35
Price / Book -8.43

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0311
Trailing P/E Ratio -3.44
PEG Ratio 0.55
P/E Growth 0.55
Net Income $-4.87M
Net Margin -6966.13%
Pretax Margin -6966.13%
Return on Equity 1364.98%
Return on Assets -748.72%

Financials Score

AltmanZ Score -139.44
Piotroski Score 3.00
Working Capital -1.15M
Total Assets 670.52K
Ebit -4.9M
Market Cap 17.11M
Total Liabilities 2.72M

Poll Results

About VentriPoint Diagnostics Ltd. (TSXV:VPT.V) Stock

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart is ... sues. The company was incorporated in 2004 and is based in Toronto, Canada.

Frequently Asked Questions

What is the current VentriPoint Diagnostics Ltd. (VPT.V) stock price?

VentriPoint Diagnostics Ltd.(TSXV:VPT.V) stock price is $0.11 in the last trading session. During the trading session, VPT.V stock reached the peak price of $0.36 while $0.11 was the lowest point it dropped to. The percentage change in VPT.V stock occurred in the recent session was --8.33% while the dollar amount for the price change in VPT.V stock was -$-0.01.

VPT.V's industry and sector of operation?

The TSXV listed VPT.V is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of VPT.V?

Mr. Hugh MacNaught | Interim Chief Executive Officer, President & Director
Matt Dobson | Marketing Director
Mr. Bart Hendriks | Strategic Partnership Executive
Mr. Hirotaka Katagiri | Chief Technology Officer & Business Development Division Director
Mr. Jim Graba | Application Specialist & Chief Trainer

How many employees does VPT.V have?

Number of VPT.V employees currently stands at None. VPT.V operates from 18 Hook Avenue, Toronto, ON M6P 1T4, CA.

Link for VPT.V official website?

Official Website of VPT.V is: https://www.ventripoint.com

How do I contact VPT.V?

VPT.V could be contacted at phone #416-848-4156 and can also be accessed through its website. VPT.V operates from 18 Hook Avenue, Toronto, ON M6P 1T4, CA.

How many shares of VPT.V are traded daily?

The average number of VPT.V shares traded daily for last 3 months was 154.11K.

What is the market cap of VPT.V currently?

The market value of VPT.V currently stands at $17.11M with its latest stock price at $0.11